Cargando…

Augmentative Asenapine in a Recurrent Manic Catatonic Patient with Partial Response to Clozapine

Catatonia is a severe but treatable neuropsychiatric syndrome known since the middle of the nineteenth century. It has been considered for a long time as a subtype of schizophrenia, even though this association occurs only in 10% of cases. In contrast, it is frequently observed in bipolar patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Buoli, Massimiliano, Dobrea, Cristina, Caldiroli, Alice, Cremaschi, Laura, Altamura, A. Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792509/
https://www.ncbi.nlm.nih.gov/pubmed/24171130
http://dx.doi.org/10.1155/2013/503601
Descripción
Sumario:Catatonia is a severe but treatable neuropsychiatric syndrome known since the middle of the nineteenth century. It has been considered for a long time as a subtype of schizophrenia, even though this association occurs only in 10% of cases. In contrast, it is frequently observed in bipolar patients. First-line treatment consists of benzodiazepines, while in case of resistance electroconvulsive therapy (ECT) and clozapine have shown positive results. In addition, recent studies reported the efficacy of some atypical antipsychotics. The present case shows the clinical response to augmentative asenapine in a catatonic manic patient with a partial response to clozapine.